Sonia Vega
Sonia Vega
Institute BIFI - University of Zaragoza
Verified email at
Cited by
Cited by
Catalytic efficiency and vitality of HIV-1 proteases from African viral subtypes
A Velazquez-Campoy, MJ Todd, S Vega, E Freire
Proceedings of the National Academy of Sciences 98 (11), 6062-6067, 2001
Amplification of the effects of drug resistance mutations by background polymorphisms in HIV-1 protease from African subtypes
A Velazquez-Campoy, S Vega, E Freire
Biochemistry 41 (27), 8613-8619, 2002
Effects of melatonin implants during non‐breeding season on sperm motility and reproductive parameters in Rasa Aragonesa rams
A Casao, S Vega, I Palacín, R Pérez‐Pe, A Laviña, FJ Quintín, E Sevilla, ...
Reproduction in domestic animals 45 (3), 425-432, 2010
Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening
O Abian, D Ortega-Alarcon, A Jimenez-Alesanco, L Ceballos-Laita, ...
International journal of biological macromolecules 164, 1693-1703, 2020
Thermodynamic rules for the design of high affinity HIV-1 protease inhibitors with adaptability to mutations and high selectivity towards unwanted targets
H Ohtaka, S Muzammil, A Schön, A Velazquez-Campoy, S Vega, E Freire
The international journal of biochemistry & cell biology 36 (9), 1787-1799, 2004
Identification of a drug targeting an intrinsically disordered protein involved in pancreatic adenocarcinoma
JL Neira, J Bintz, M Arruebo, B Rizzuti, T Bonacci, S Vega, A Lanas, ...
Scientific reports 7 (1), 1-15, 2017
Structural and thermodynamic basis of resistance to HIV-1 protease inhibition: implications for inhibitor design
A Velazquez-Campoy, S Muzammil, H Ohtaka, A Schon, S Vega, E Freire
Current Drug Targets-Infectious Disorders 3 (4), 311-328, 2003
A structural and thermodynamic escape mechanism from a drug resistant mutation of the HIV‐1 protease
S Vega, LW Kang, A Velazquez‐Campoy, Y Kiso, LM Amzel, E Freire
Proteins: Structure, Function, and Bioinformatics 55 (3), 594-602, 2004
A unified framework based on the binding polynomial for characterizing biological systems by isothermal titration calorimetry
S Vega, O Abian, A Velazquez-Campoy
Methods 76, 99-115, 2015
Protease inhibition in African subtypes of HIV-1
A Velázquez-Campoy, S Vega, E Fleming, U Bacha, Y Sayed, HW Dirr, ...
Aids Rev 5 (3), 165-171, 2003
On the link between conformational changes, ligand binding and heat capacity
S Vega, O Abian, A Velazquez-Campoy
Biochimica et Biophysica Acta (BBA)-General Subjects 1860 (5), 868-878, 2016
A look at ligand binding thermodynamics in drug discovery
R Claveria-Gimeno, S Vega, O Abian, A Velazquez-Campoy
Expert opinion on drug discovery 12 (4), 363-377, 2017
Deconvolution analysis for classifying gastric adenocarcinoma patients based on differential scanning calorimetry serum thermograms
S Vega, MA Garcia-Gonzalez, A Lanas, A Velazquez-Campoy, O Abian
Scientific reports 5, 7988, 2015
Allosteric inhibitors of the NS3 protease from the hepatitis C virus
O Abian, S Vega, J Sancho, A Velazquez-Campoy
PLoS One 8 (7), e69773, 2013
Conformational stability of hepatitis C virus NS3 protease
O Abian, S Vega, JL Neira, A Velazquez-Campoy
Biophysical journal 99 (11), 3811-3820, 2010
Protein-cation interactions: structural and thermodynamic aspects
X Arias-Moreno, O Abian, S Vega, J Sancho, A Velazquez-Campoy
Current Protein and Peptide Science 12 (4), 325-338, 2011
The intervening domain from MeCP2 enhances the DNA affinity of the methyl binding domain and provides an independent DNA interaction site
R Claveria-Gimeno, PM Lanuza, I Morales-Chueca, OC Jorge-Torres, ...
Scientific reports 7 (1), 1-16, 2017
Thermal liquid biopsy for monitoring melanoma patients under surveillance during treatment: A pilot study
A Velazquez-Campoy, S Vega, O Sanchez-Gracia, A Lanas, A Rodrigo, ...
Biochimica et Biophysica Acta (BBA)-General Subjects 1862 (8), 1701-1710, 2018
Zinc induced folding is essential for TIM15 activity as an mtHsp70 chaperone
H Fraga, E Papaleo, S Vega, A Velazquez-Campoy, S Ventura
Biochimica et Biophysica Acta (BBA)-General Subjects 1830 (1), 2139-2149, 2013
Rutin is a low micromolar inhibitor of SARS-CoV-2 main protease 3CLpro: implications for drug design of quercetin analogs
B Rizzuti, F Grande, F Conforti, A Jimenez-Alesanco, L Ceballos-Laita, ...
Biomedicines 9 (4), 375, 2021
The system can't perform the operation now. Try again later.
Articles 1–20